Search

Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for almost half of all dialysis patients and life expectancy on dialysis is just one-third of that for the general population.

Invizius awarded major funding to bring dialysis treatment to clinic

Invizius wins second Biomedical Catalyst Grant to take H-Guard into new field

University spinouts named in Scotland’s top tech startups

Four University of Edinburgh-supported companies have been named in Scotland’s Top 15 Tech Startups in recent analysis by data experts Beauhurst.

Engineering biology for better global health

Taking an engineering approach to building biological systems – engineering biology – has spectacular potential to revolutionise how we diagnose and treat disease.

Old College Capital

Old College Capital (OCC) is the University of Edinburgh’s venture investment fund. We manage Edinburgh’s early-stage investment activities and shareholdings; supporting exciting ideas and technologies emerging from the University.

Global Entrepreneurship Week 2023

At the University of Edinburgh we’ve created an entrepreneurial ecosystem to match our entrepreneurial mindset.

Our Expertise

Our Campaigns

Collaboration

Venture Investment

Search

Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for almost half of all dialysis patients and life expectancy on dialysis is just one-third of that for the general population.